Latest News and Press Releases
Want to stay updated on the latest news?
-
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration...
-
REYKJAVIK, ISLAND (20 augusti 2025) — Alvotech (NASDAQ: ALVO), ett globalt bioteknikföretag som specialiserat sig på utveckling och tillverkning av biosimilarer för patienter över hela världen,...
-
REYKJAVIK, ICELAND (August 20, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
-
Company to host conference call and webcast on Thursday, August 28th at 8:30am EDT AUSTIN, Texas, August 7, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
-
PHOENIX, AZ, July 31, 2025 (GLOBE NEWSWIRE) -- Walter P Moore has expanded into Phoenix, Arizona, enhancing its ability to deliver innovative engineering solutions in one of the nation’s...
-
MCLEAN, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion”), a leader in innovative, high-margin cybersecurity solutions, attended the National Association of County...
-
Aztiq sells Adalvo, one of the leading business-to-business pharmaceutical companies in Europe founded in 2018, to EQT, a global investment organization.
-
MCLEAN, Va., July 11, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion”), a leader in IT cybersecurity solutions and AI, today announced that Michael A. Phillips, Vice President of...
-
REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún...
-
REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...